Hot Stocks: SEEK, Dexus, Golden Horse Minerals, Enlitic

[videojs_video url=’https://du7x25at22z7c.cloudfront.net/HS_18022025_V1/single_720p.mp4′ poster=’http://www.finnewsnetwork.com.au/newssystem/seqcmsfiles/2025/02/fuzXHYDoarKQK8Q4tHqb_1920x1080_44776.jpg’]

Australian shares were flat at the open as traders responded to mixed bag of earnings results from ASX-listed companies.

The S&P/ASX 200 slipped 0.2 per cent, or 14.5 points lower to 8522.60 at the open, with BHP, Challenger and Reliance Worldwide Corporation weighing on the index. Futures had predicted the index would open higher.

SEEK Limited (ASX:SEK) reported a 4% drop in revenue and a 28% decline in adjusted profit, impacted by lower job ad volumes. Though Reported profit surged to $143.5m, aided by SEEK Growth Fund gains. The interim dividend rose to 24 cents, supported by a 93% increase in free cash flow. Despite the revenue drop, SEEK achieved double-digit yield growth and continued investment in AI-driven job matching. Shares are trading 0.12% lower at $24.20.

Dexus (ASX:DXS) returned to profit with $10.3m in the six months to December, rebounding from a $597.2m loss a year earlier, as property valuation losses eased. Revenue dropped 9.6% to $434.7m, while funds from operations fell 7.4% to $337.8m, impacted by higher interest rates and lower trading profits. Net tangible assets per share declined to $8.81 from $8.97. The company cut its distribution to 19¢ per share, down from 26.7¢. Shares are trading 0.38% lower at $7.79.

Golden Horse Minerals (ASX:GHM) has reported high-grade assay results from four initial drill holes at its Hopes Hill project, supporting its flagship status. Managing Director Nicholas Anderson called the results promising, following strong outcomes at Hakes Find. More results, including from hole GHHHRC0004, are expected soon. The Phase 1 drill program continues for 3-4 weeks to validate historic data and refine targeting. Shares are trading 16.7% higher at 31.5c.

Enlitic (ASX:ENL) and its subsidiary Laitek have announced a strategic collaboration with GE HealthCare to enhance AI-driven medical imaging data migration. Expanding on an existing agreement, the partnership aims to streamline large-scale migrations for GE HealthCare’s Enterprise Imaging solutions. Key features include AI-powered automation for faster transitions, cloud-based scalability, data standardization and compliance, and high-performance migration tools to improve imaging data quality and interoperability. Shares are trading 15.25% higher at 6.8 cents.

Click here to register for tomorrow’s Sip & Learn webinar discussing biotech and resources, featuring Alterity Therapeutics, Nico Resource and Immutep.